ClosedHealth & Human Services
Teen Pregnancy Prevention Tier 2 Rigorous Evaluation Cooperative Agreements
Office of the Assistant Secretary for HealthAH-TP2-23-001
Description
The Office of Population Affairs (OPA), in the Office of the Assistant Secretary for Health, administers the Title X family planning, Teen Pregnancy Prevention (TPP), and Embryo Adoption Awareness and Services programs. OPA advises the Secretary and the Assistant Secretary for Health on a wide range of reproductive and adolescent health topics. The TPP program was established in 2010 with a Congressional mandate to fund medically accurate and age-appropriate programs to reduce teen pregnancy and associated risk behaviors. The purpose of the TPP Tier 2 Rigorous Evaluation Cooperative Agreements is to fund rigorous impact and implementation evaluation of promising approaches for preventing teen pregnancy and related risk behaviors. Through the awards, OPA aims to address the changing needs of youth and communities by increasing the number of programs available that are proven to reduce teen pregnancy, sexually transmitted infections (STIs), and behavioral risk factors underlying teen pregnancy, and to disseminate those interventions that demonstrate effectiveness. OPA is especially interested in funding rigorous evaluations of promising interventions in populations and settings with great need and those that demonstrate significant health disparities, such as, but not limited to, interventions in juvenile justice or foster care/child welfare settings, with expectant and parenting youth, youth with disabilities, with homeless youth, or for caregivers. A wide range of adolescent health innovations may be proposed for study under this funding opportunity, such as, but not limited to, programs, curricula, clinical interventions, and technological interventions. Promising interventions to be evaluated under the funding opportunity are expected to have compelling, positive preliminary evidence from previous research, a well-described theory of change, and intervention materials that are already developed. The promising intervention should also have demonstrated support from participants and be a good fit for the intended population and setting proposed for the evaluation. Funded recipients are expected to conduct a rigorous impact evaluation of the promising intervention with the most robust possible design that is feasible for the intervention and setting. All funded recipients will be expected to participate in OPA evaluation technical assistance. Recipients will be expected to conduct high-quality implementation of the intervention by maintaining fidelity, quality assurance, high dosage, intervention saturation, appropriate materials, staff coordination and management, qualified facilitators, participant engagement and satisfaction, and stakeholder support. Promising interventions proposed for evaluation under this funding are expected to have the potential to scale and be replicated by others in the adolescent health field. Funded recipients will be expected to disseminate their evaluation findings and lessons learned through publications in peer-reviewed journals and presentations at professional conferences.
Award Ceiling
$1.0M
Award Floor
$500K
Total Funding
$11.5M
CFDA Number
93.297
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
March 10, 2023
Close Date
May 17, 2023
Posted Date
March 10, 2023
Eligible Applicant Types
Public and State controlled institutions of higher educationPublic housing authorities/Indian housing authoritiesCounty governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationSpecial district governmentsNative American tribal governments (Federally recognized)Native American tribal organizations (other than Federally recognized tribal governments)Private institutions of higher educationState governmentsIndependent school districtsFor profit organizations other than small businessesCity or township governmentsSmall businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Tags
HHS-OPHSCFDA:93.297Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left